Mr. George Robinson reports

RAVENQUEST BIOMED COMMENTS ON HISTORIC SENATE VOTE PASSING CANADA'S CANNABIS ACT

Ravenquest Biomed Inc. has commented on the historic vote in Canada's upper chamber on June 19, 2018, which passed with 52 votes for, 29 votes against and two abstentions. Under Canada's constitution, Bill C-45 will now be sent to the Governor General to make royal ascent; at which point, it will become the law of the land and adult recreational use of cannabis will be federally legal across Canada.

George Robinson, chief executive officer of Ravenquest Biomed, commented: "We are extremely pleased and welcome the passage of this historic bill into law. We wish to thank the contributions from all sides of the ongoing conversation around cannabis legalization. This includes the crucial, and often risky, early efforts by activists and advocates as well as the ongoing contributions from educators, research scientists, law enforcement, public health officials, physicians, lawmakers and so many more. We encourage all stakeholders to continue this conversation as we move towards implementing the regulatory framework which will put this legislation into action. Much needs to be accomplished to ensure public safety, education and awareness come to the forefront as we implement C-45. As a company that believes emphatically in social responsibility, we continue to emphasize the government of Canada's stated priority to include indigenous communities in all major new economies affecting Canadians. We are confident that the appropriate steps will be taken by parliament and its committees to ensure indigenous communities are afforded the chance to participate in this unprecedented economic opportunity.

"Canada will now officially become the first G7 nation to legalize adult recreational marijuana use federally. After 90 years of prohibition, this is a historic milestone with potentially global implications. The world will be watching as Canada takes a leadership role in lifting prohibition. As we move toward the implementation of the Cannabis Act, I encourage all industry participants to lead responsibly, taking the care and caution that comes with stewardship of a new era."

About Ravenquest Biomed Inc.

Ravenquest Biomed is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services and consulting, and specialized research and development.